Ancient Times (circa 400 BCE and onward)
Early Greek physicians used the word “herpes,” meaning “to creep,” to describe skin lesions that appeared to spread across the body. This was a descriptive term for symptoms, not a known viral infection.
Ancient Roman physicians such as Aulus Cornelius Celsus documented various skin conditions and treatments, including cauterization for some lesions. At the time, different skin diseases were not clearly distinguished from one another.
Early Modern Literary References (1500s)
William Shakespeare occasionally used imagery of lip sores (possibly HSV-1) and blisters in his writing. These were literary descriptions of common human experiences, not medical definitions of herpes.
18th to 19th Century
Skin and genital lesions were often grouped under broad, sometimes moralized, medical categories. Physicians gradually began distinguishing between different conditions, including what would later be understood as syphilis, eczema, and recurrent ulcerative diseases.
Mid to Late 1800s
Dermatologists such as Charles-Paul Diday contributed to early clinical descriptions of recurrent genital ulcer disease, an early understanding of what would later be classified as genital herpes (HSV-2). Medical professionals began recognizing that some conditions could be transmitted from person to person, although the viral cause remained unknown.
Late 1800s
Paul Gerson Unna and other dermatologists advanced the microscopic study of skin tissue. They observed cellular changes in lesions but could not yet identify viruses, as viral visualization was not possible at the time.
Early 1900s
Early experimental virology began to emerge. Researchers such as Ernest Goodpasture developed methods for studying viruses in animal models, including embryonated eggs and tissue experiments. Herpes Simplex Virus was studied in laboratory animals such as rabbits, which helped scientists understand its behavior in tissues, but this was not used as a clinical diagnostic test.
Mid 1900s
Scientific research established that the Herpes Simplex Virus is neurotropic. It infects sensory nerves, travels along nerve pathways, and remains dormant in nerve ganglia before reactivating. This understanding developed gradually through the work of multiple researchers and experiments over several decades.
1970s
Researchers, including Jack Stevens and Marjorie Cook, contributed to demonstrating viral latency in nerve tissue, helping confirm how herpes persists in the body.
1960s–1980s (diagnosis and treatment advances)
Arnaud Tzanck developed the Tzanck smear, an early laboratory test that could identify viral infection in cells but could not specifically distinguish herpes from other similar viruses. Acyclovir, developed by Gertrude Elion and colleagues at Burroughs Wellcome, became one of the first highly effective antiviral treatments for HSV and remains widely used today.
Modern Understanding (late 20th century to present)
Modern research confirms that HSV-1 and HSV-2 establish lifelong latency in nerve ganglia and can reactivate periodically. Genetic studies suggest herpes viruses have co-evolved with human ancestors for millions of years. HSV-2 likely crossed into early human ancestors from primate species approximately 1.5 to 2 million years ago, although the exact ancestral species cannot be definitively identified.
Back to HSV Q & A.
Add comment
Comments